Organigram Global Inc. announced record results for its third quarter ended June 30, 2025, with gross revenue reaching $110.2 million, a 73% increase year-over-year and a 7.2% sequential rise. Net revenue also hit a record $70.8 million, up 72% year-over-year and 7.9% sequentially.
International revenue contributed $7.4 million to the quarter's results, marking a substantial 208% year-over-year increase. The company's adjusted gross margin rate was 34%, a sequential improvement of 100 basis points, driven by contributions from Motif and Collective Project acquisitions.
Adjusted EBITDA for Q3 Fiscal 2025 reached $5.7 million, a 64% increase year-over-year, primarily due to higher international sales and increased recreational net revenue. Organigram generated $14.6 million in cash flow from operations, a significant improvement from a cash use of $3.7 million in the prior year.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.